title: N-(4-18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes.
abstract: Interleukin-2 (IL2) binds with high affinity to the IL2 receptors overexpressed on activated T lymphocytes in various pathologic conditions. Radiolabeling of IL2 with a positron-emitting isotope could provide a tool for noninvasive PET of activated T cells in immune-mediated diseases. We report the labeling of IL2 with N-succinimidyl 4-(18)F-fluorobenzoate ((18)F-SFB) for the synthesis of N-(4-(18)F-fluorobenzoyl)interleukin-2 ((18)F-FB-IL2) and the in vitro and in vivo evaluation of this novel radiopharmaceutical for the detection of IL2 receptor-positive cells by PET.
  
  
  METHODS
  (18)F-SFB was efficiently prepared using a 3-step radiochemical pathway. Purified (18)F-SFB was incubated with IL2 in borate buffer (pH 8.5) and ethanol at 50°C for 10 min. (18)F-FB-IL2 was purified by reversed-phase high-performance liquid chromatography. As in vitro quality controls, a biologic binding assay, sodium dodecyl sulfate polyacrylamide gel electrophoresis, mass spectrometry, and 3-chloroacetic acid precipitation stability tests were performed. Biodistribution studies were performed in BALB/c mice to evaluate the distribution of the tracer in healthy animals. PET experiments were performed in severe combined immunodeficiency disease mice inoculated with phytohemoagglutinin-activated human peripheral blood mononuclear cells (hPBMc). Whole-body images were acquired 30 min after injection of 5-15 MBq of (18)F-FB-IL2.
  
  
  RESULTS
  (18)F-SFB was produced with a 34%-38% radiochemical yield. The radiochemical purity after solid-phase extraction purification ranged from 93% to 96%. Conjugation of (18)F-SFB to IL2 yielded (18)F-FB-IL2 as the major product. The radiochemical yield of (18)F-FB-IL2 after high-performance liquid chromatography purification was 25%-35% based on (18)F-SFB. (18)F-FB-IL2 was stable in plasma at 37°C and capable of stimulating T cells to an extent similar to native IL2. A biodistribution study showed highest tracer uptake in the kidneys and bladder due to rapid renal clearance of the tracer. Small-animal PET images showed binding of (18)F-FB-IL2 to activated hPBMc proportional to the number of injected cells.
  
  
  CONCLUSIONS
  We report the successful labeling of IL2 with (18)F for PET of activated T lymphocytes. (18)F-FB-IL2 is stable, is biologically active, and allows in vivo detection of activated T lymphocytes.
authors.affiliation: Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
authors.forename: Valentina
authors.initials: V
authors.lastname: Di Gialleonardo
authors.forename: Alberto
authors.initials: A
authors.lastname: Signore
authors.forename: Andor W J M
authors.initials: AW
authors.lastname: Glaudemans
authors.forename: Rudi A J O
authors.initials: RA
authors.lastname: Dierckx
authors.forename: Erik F J
authors.initials: EF
authors.lastname: De Vries
mesh_terms: D000818:Animals; D001565:Benzoates / Q000737:chemistry; D049109:Cell Proliferation / Q000187:drug effects; D004355:Drug Stability; D006801:Humans; D007376:Interleukin-2 / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics; D051379:Mice; D049268:Positron-Emission Tomography / Q000379:methods*; D011786:Quality Control; D015203:Reproducibility of Results; D013388:Succinimides / Q000737:chemistry; D013601:T-Lymphocytes / Q000166:cytology* / Q000000981:diagnostic imaging*
chemical_list: D001565:Benzoates; D007376:Interleukin-2; C572953:N-(4-fluorobenzoyl)interleukin-2; D013388:Succinimides; C075713:N-succinimidyl-4-fluorobenzoate